These observations suggest that recruiting B cells into the TLS of the tumor become less effective in EGFR-MT, likely due to a loss of CXCL13–CXCR5-mediated interactions, resulting in reduced cytotoxic T cell activation. Here, CXCL13 is linked to neoplasm.